APA (7th ed.) Citation

Chatur, S., Vaduganathan, M., Fletcher, R. A., Perkovic, V., Heerspink, H., Arnott, C., . . . Neuen, B. L. (2025). Canagliflozin reduces oral loop diuretic intensification in patients with type 2 diabetes: A participant‐level pooled analysis of the CANVAS and CREDENCE trials. European Journal of Heart Failure, 27(6), 994. https://doi.org/10.1002/ejhf.3586

Chicago Style (17th ed.) Citation

Chatur, Safia, et al. "Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant‐level Pooled Analysis of the CANVAS and CREDENCE Trials." European Journal of Heart Failure 27, no. 6 (2025): 994. https://doi.org/10.1002/ejhf.3586.

MLA (9th ed.) Citation

Chatur, Safia, et al. "Canagliflozin Reduces Oral Loop Diuretic Intensification in Patients with Type 2 Diabetes: A Participant‐level Pooled Analysis of the CANVAS and CREDENCE Trials." European Journal of Heart Failure, vol. 27, no. 6, 2025, p. 994, https://doi.org/10.1002/ejhf.3586.